PEEK Material in Spinal Fusion Surgery: A Clinical Alternative to Traditional Titanium Implants

Background and Patient Challenges

In 2023, the orthopedic department of a tertiary hospital in China treated a 52-year-old patient with lumbar disc herniation. The patient had previously undergone titanium interbody fusion cage implantation, and two years post-surgery, experienced accelerated adjacent segment degeneration (ASD). Imaging revealed that the high rigidity of the titanium cage caused stress shielding, leading to significant bone mineral density loss in adjacent vertebrae. For the revision surgery, the medical team urgently needed a material with biomechanical properties closer to natural bone to minimize interference with surrounding tissues.

Material Selection Rationale

Polyether Ether Ketone (PEEK) is a high-performance engineering polymer with an elastic modulus of approximately 3-4 GPa — far more closely matched to human cancellous bone (0.1-1 GPa) and cortical bone (15-20 GPa) than titanium alloy (110 GPa). PEEK’s radiolucency enables crystal-clear postoperative CT and MRI imaging without artifact interference, allowing physicians to accurately assess fusion status. PEEK also demonstrates excellent biocompatibility, validated through ISO 10993 series certification, with no adverse reactions reported for long-term human implantation.

Solution Implementation

The medical team performed a revision surgery using a domestically manufactured PEEK interbody fusion cage (Model IFC-PEEK-L4/5) via a Posterior Lumbar Interbody Fusion (PLIF) approach, precisely placed with navigation assistance. The PEEK cage features a porous structure (approximately 60% porosity) with plasma-sprayed surface treatment to enhance bone integration. Combined with postoperative rehabilitation, the patient began ambulation on day 3, reducing hospital stay by approximately 40%.

Clinical Outcomes and Data Comparison

• Fusion Rate: 12-month follow-up CT showed a fusion rate of 94.7%, approximately 5.5 percentage points higher than historical titanium cage data (89.2%)
• ASD Incidence: Within 24-month follow-up, ASD occurrence rate was 8.3%, significantly lower than the titanium group (22.1%)
• Imaging Quality: PEEK group averaged 4.6/5.0 for image clarity, compared to only 2.1/5.0 for the titanium group
• Patient Satisfaction: Based on ODI (Oswestry Disability Index) scores, patient satisfaction with functional recovery reached 91%

Conclusion

PEEK interbody fusion cages demonstrate significant clinical advantages in spinal fusion surgery due to their bone-matched elastic modulus, excellent radiolucency, and superior biocompatibility. For patients requiring revision surgery or those at risk of osteoporosis, PEEK offers superior biomechanical compatibility. As domestic PEEK fusion cage manufacturing matures and costs decline, its adoption in spinal surgery is expected to expand substantially.